Notizie sul Mercato Azionario
Ultime notizie finanziarie · Aggiornato Lug 28, 2026
Leerink Partners Aumenta PT su Oruka Therapeutics, Inc. (ORKA)
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
ORKA-001's Phase 2a results are impressive, but its path to market is uncertain due to manufacturing challenges, competition, and commercial …
AnaptysBio (ANAB) è uno dei titoli sanitari con le migliori performance finora nel 2026?
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?
The panel is divided on ANAB's spinoff of TRAX, with some seeing it as a value-enhancing move that separates stable …
Revolution Medicines (RVMD) Riceve Lettera "Safe to Proceed" dalla FDA per Daraxonrasib
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
The panel is mixed on RVMD's 'safe to proceed' EAP, with concerns about the lack of efficacy data, manufacturing challenges, …
RBC Capital Aumenta PT su Acadia Healthcare Company (ACHC) Dopo il Superamento degli Utili del Q1
RBC Capital Lifts PT on Acadia Healthcare Company (ACHC) Following Q1 Earnings Beat
While ACHC's Q1 earnings beat and upgrades suggest potential for EBITDA improvement and a 'harvest' from underperforming facilities, the consensus …
Twist Bioscience Corporation (TWST) Annuncia i Risultati Finanziari del Q2 2026
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
The panelists agree that Twist Bioscience has shown operational momentum with 13 consecutive quarters of growth and a 19% YoY …
Goldman Sachs rivede al ribasso le previsioni sul titolo Broadcom
Goldman Sachs resets Broadcom stock forecast
The panel is divided on Broadcom's VMware integration, with bulls focusing on potential margin expansion and AI momentum, while bears …
RBC Capital Aumenta PT su CG Oncology (CGON), Definisce PIVOT-006 un Catalizzatore Complesso
RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst
CG Oncology's stock performance is heavily reliant on the June PIVOT-006 data, with a high risk of a 'sell the …
Highlights della Chiamata degli Utimi Quartali di W.W. Grainger
W.W. Grainger Q1 Earnings Call Highlights
Panelists have mixed views on Grainger's Q1 results and future prospects. While some highlight the impressive EPS growth and margin …
Azioni Europee Viste Aprire Su Nota Cauta
European Shares Seen Opening On Cautious Note
The panelists generally agree that European stocks face headwinds due to stretched valuations and uncertainty around central bank policies, with …
Hanwha Life Insurance Utile Trimestrale Sale Grazie a Crescita Vendite; Azioni Su
Hanwha Life Insurance Q1 Profit Climbs On Sales Growth; Shares Up
Hanwha Life's impressive Q1 results, with net income up 43.5% and sales surging 54.7%, are being scrutinized due to a …
Questo titolo di chip sottovalutato ha appena fatto qualcosa che non faceva da un anno. È ora di comprare?
This Beaten-Down Chip Stock Just Did Something It Hasn't Done in a Year. Time to Buy?
Despite positive Q2 guidance, Impinj's high forward P/E multiple (74x) is seen as unsustainable by most panelists, who caution against …
Kawasaki Heavy Industries Utile Fiscale 25 Aumenta, Prevede Crescita Nell'Anno Fiscale 26; Azioni Guadagnano
Kawasaki Heavy Industries FY25 Profit Climbs, Sees Growth In FY26; Stock Gains
Despite strong revenue growth, Kawasaki Heavy's guidance for significantly slower net profit growth raises concerns about margin sustainability. The market …